Merrell Dow's Seldane
Executive SummaryDow Chemical President Paul Oreffice predicted at firm's annual meeting that worldwide sales for the non-sedating antihistamine are expected to reach $60 mil. this year and $100 mil. in 1986. The price to whslrs. is $35.80 for a bottle of 100 60 mg tablets. "The Pink Sheet" (May 13, p. 3) gave a figure of $43.21. The average whsle. price is $43.86.
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.